Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
COLL · against 1,336 other Healthcare companies
Ranked #102 of 1,337 · scores higher than 92% of peers
Bars: peers in each 10-point band of the valuation score141 peers with a valuation score of 90–100, including COLL · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | COLL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 5.4% | 1.5% | 80% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 21.8% | 4.2% | 95% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 42.5% | -1.0% | 99% | 20% | |
| Book yieldHigher is better · 1,306 reported | 40.4% | 37.9% | 53% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 102 | 26.5B CNY (≈$3.7B) | 92 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 69 |
| 102 | 1.6B HKD (≈$209M) | 92 | 54 |
| 102 | 1.1B MYR (≈$245M) | 92 | 70 |
| 102 | 301M USD | 92 | 67 |
| 102 | 773M USD | 92 | 64 |
| 102 | 11.6B USD | 92 | 57 |
| 102 | 2.2B USD | 92 | 78 |
| 102 | 251M EUR (≈$276M) | 92 | 52 |
| 102 | 2.91T IDR (≈$180M) | 92 | 50 |